FDA.reportPublic FDA data

Application 211248

Type
ANDA
Sponsor
YILING

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PAROXETINE HYDROCHLORIDEPAROXETINE HYDROCHLORIDETABLET;ORALEQ 10MG BASENoNo
002PAROXETINE HYDROCHLORIDEPAROXETINE HYDROCHLORIDETABLET;ORALEQ 20MG BASENoNo
003PAROXETINE HYDROCHLORIDEPAROXETINE HYDROCHLORIDETABLET;ORALEQ 30MG BASENoNo
004PAROXETINE HYDROCHLORIDEPAROXETINE HYDROCHLORIDETABLET;ORALEQ 40MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69117-0024ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0024ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0024ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0024ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0025ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0025ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0025ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0025ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0026ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0026ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0026ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0026ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0027ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0027ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0027ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent
69117-0027ParoxetineParoxetineYiling Pharmaceutical, Inc.ANDACurrent